通过体积测量评估结直肠癌肝转移灶体积的预后效果。

IF 3 4区 医学 Q2 ONCOLOGY Future oncology Pub Date : 2024-10-08 DOI:10.1080/14796694.2024.2406221
İlknur Deliktaş Onur, Pınar Özdemir Akdur, Elif Sertesen Çamöz, Nazan Çiledağ, Fatih Yıldız
{"title":"通过体积测量评估结直肠癌肝转移灶体积的预后效果。","authors":"İlknur Deliktaş Onur, Pınar Özdemir Akdur, Elif Sertesen Çamöz, Nazan Çiledağ, Fatih Yıldız","doi":"10.1080/14796694.2024.2406221","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> To evaluate the relationship between liver metastasis volume and survival in colorectal cancer patients using the volumetric measurement method.<b>Methods:</b> 114 colorectal cancer patients with isolated liver metastases were included in the study. Liver tumor volume, total liver volume were calculated from the patients images at the time of diagnosis. Vitrea 7.14 imaging software was used for liver volume analysis and volume analysis of each metastasis.<b>Results:</b> Median overall survival(OS) in the group with tumor volume <42 ml<sup>3</sup> was 30.98 months In the group with tumor volume ≥42 ml<sup>3</sup>, median OS was 16.36 months (<i>p</i>: 0.001). In patients who underwent metastasectomy, the median OS in the group with a tumor volume <42 ml<sup>3</sup> was 52.3 months, the median OS in the group with a tumor volume ≥42 ml<sup>3</sup> was 22.2 months. In patients who did not undergo metastasectomy, the median OS in the <42 ml<sup>3</sup> group was 20.23 months, the median OS in the ≥42 ml<sup>3</sup> group was 15.63 months.<b>Conclusion:</b> In our study, we found that liver metastasis volume was prognostic for OS. It is argued that tumor volume measurement by volumetric measurement is a widely used method in the decision for metastasectomy in liver metastatic colorectal cancer patients.</p>","PeriodicalId":12672,"journal":{"name":"Future oncology","volume":" ","pages":"1-8"},"PeriodicalIF":3.0000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of the prognostic effectiveness of liver metastasis volume by volumetric measurement in colorectal cancer.\",\"authors\":\"İlknur Deliktaş Onur, Pınar Özdemir Akdur, Elif Sertesen Çamöz, Nazan Çiledağ, Fatih Yıldız\",\"doi\":\"10.1080/14796694.2024.2406221\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Aim:</b> To evaluate the relationship between liver metastasis volume and survival in colorectal cancer patients using the volumetric measurement method.<b>Methods:</b> 114 colorectal cancer patients with isolated liver metastases were included in the study. Liver tumor volume, total liver volume were calculated from the patients images at the time of diagnosis. Vitrea 7.14 imaging software was used for liver volume analysis and volume analysis of each metastasis.<b>Results:</b> Median overall survival(OS) in the group with tumor volume <42 ml<sup>3</sup> was 30.98 months In the group with tumor volume ≥42 ml<sup>3</sup>, median OS was 16.36 months (<i>p</i>: 0.001). In patients who underwent metastasectomy, the median OS in the group with a tumor volume <42 ml<sup>3</sup> was 52.3 months, the median OS in the group with a tumor volume ≥42 ml<sup>3</sup> was 22.2 months. In patients who did not undergo metastasectomy, the median OS in the <42 ml<sup>3</sup> group was 20.23 months, the median OS in the ≥42 ml<sup>3</sup> group was 15.63 months.<b>Conclusion:</b> In our study, we found that liver metastasis volume was prognostic for OS. It is argued that tumor volume measurement by volumetric measurement is a widely used method in the decision for metastasectomy in liver metastatic colorectal cancer patients.</p>\",\"PeriodicalId\":12672,\"journal\":{\"name\":\"Future oncology\",\"volume\":\" \",\"pages\":\"1-8\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/14796694.2024.2406221\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14796694.2024.2406221","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:采用体积测量法评估结直肠癌患者肝转移灶体积与生存率之间的关系。方法:研究纳入了114名有孤立肝转移灶的结直肠癌患者。肝脏肿瘤体积和肝脏总体积根据患者确诊时的图像计算得出。使用Vitrea 7.14成像软件进行肝脏体积分析和各转移灶的体积分析:肿瘤体积3组的中位总生存期(OS)为30.98个月,肿瘤体积≥42 ml3组的中位总生存期为16.36个月(P:0.001)。在接受转移灶切除术的患者中,肿瘤体积为 3 的组的中位生存期为 52.3 个月,肿瘤体积≥42 ml3 的组的中位生存期为 22.2 个月。在未进行转移灶切除术的患者中,肿瘤体积为3组的中位生存期为20.23个月,肿瘤体积≥42 ml3组的中位生存期为15.63个月:在我们的研究中,我们发现肝转移灶体积是OS的预后指标。因此,通过容积测量肿瘤体积是一种广泛应用于肝转移性结直肠癌患者转移切除术决策的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Evaluation of the prognostic effectiveness of liver metastasis volume by volumetric measurement in colorectal cancer.

Aim: To evaluate the relationship between liver metastasis volume and survival in colorectal cancer patients using the volumetric measurement method.Methods: 114 colorectal cancer patients with isolated liver metastases were included in the study. Liver tumor volume, total liver volume were calculated from the patients images at the time of diagnosis. Vitrea 7.14 imaging software was used for liver volume analysis and volume analysis of each metastasis.Results: Median overall survival(OS) in the group with tumor volume <42 ml3 was 30.98 months In the group with tumor volume ≥42 ml3, median OS was 16.36 months (p: 0.001). In patients who underwent metastasectomy, the median OS in the group with a tumor volume <42 ml3 was 52.3 months, the median OS in the group with a tumor volume ≥42 ml3 was 22.2 months. In patients who did not undergo metastasectomy, the median OS in the <42 ml3 group was 20.23 months, the median OS in the ≥42 ml3 group was 15.63 months.Conclusion: In our study, we found that liver metastasis volume was prognostic for OS. It is argued that tumor volume measurement by volumetric measurement is a widely used method in the decision for metastasectomy in liver metastatic colorectal cancer patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Future oncology
Future oncology ONCOLOGY-
CiteScore
5.40
自引率
3.00%
发文量
335
审稿时长
4-8 weeks
期刊介绍: Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community. The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting.
期刊最新文献
Sotorasib for the treatment of locally advanced/metastatic non-small cell lung cancer. Artificial intelligence and radiomics in desmoid-type fibromatosis: are we there yet? Evaluation of CDK4/6 inhibitors in first-line in symptomatic and asymptomatic patients with metastatic breast cancer. Tislelizumab for consolidation therapy in patients with pathologically residual Esophageal Squamous Cell Carcinoma after definitive concurrent Chemoradiotherapy: a multicenter, randomized, controlled phase II trial. Current practices for the management of advanced high-grade epithelial ovarian cancer in the UK: OC-NOW survey (2023).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1